Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurotoxicity Syndromes | 11 | 2023 | 302 | 4.120 |
Why?
|
Brain Neoplasms | 51 | 2024 | 9071 | 3.390 |
Why?
|
Glioblastoma | 29 | 2024 | 3459 | 3.160 |
Why?
|
Central Nervous System Neoplasms | 15 | 2024 | 916 | 2.760 |
Why?
|
Cranial Irradiation | 6 | 2024 | 385 | 2.150 |
Why?
|
Glioma | 22 | 2024 | 3493 | 1.990 |
Why?
|
Antineoplastic Agents, Alkylating | 7 | 2019 | 614 | 1.900 |
Why?
|
Lymphoma | 9 | 2024 | 1897 | 1.890 |
Why?
|
Immunotherapy, Adoptive | 12 | 2024 | 1510 | 1.800 |
Why?
|
Dacarbazine | 5 | 2016 | 552 | 1.360 |
Why?
|
Central Nervous System | 10 | 2023 | 1341 | 1.050 |
Why?
|
Antigens, CD19 | 4 | 2024 | 443 | 1.040 |
Why?
|
Radiation Injuries | 6 | 2024 | 1181 | 1.020 |
Why?
|
Brain | 22 | 2024 | 27171 | 0.880 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2021 | 1434 | 0.860 |
Why?
|
Neoplasms | 12 | 2024 | 22340 | 0.860 |
Why?
|
Stem Cells | 12 | 2010 | 3540 | 0.820 |
Why?
|
Lymphoma, Non-Hodgkin | 5 | 2021 | 1376 | 0.790 |
Why?
|
Antineoplastic Agents | 18 | 2024 | 13648 | 0.770 |
Why?
|
Leukoencephalopathies | 2 | 2024 | 259 | 0.760 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 41 | 0.720 |
Why?
|
Radiation Injuries, Experimental | 2 | 2017 | 88 | 0.690 |
Why?
|
Nervous System Diseases | 5 | 2024 | 1660 | 0.690 |
Why?
|
Vidarabine | 1 | 2020 | 343 | 0.650 |
Why?
|
Isocitrate Dehydrogenase | 7 | 2024 | 954 | 0.620 |
Why?
|
Immunotherapy | 8 | 2023 | 4752 | 0.610 |
Why?
|
Methotrexate | 2 | 2023 | 1722 | 0.600 |
Why?
|
Spinal Cord Diseases | 1 | 2021 | 290 | 0.600 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2018 | 43 | 0.600 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2019 | 47 | 0.600 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2020 | 335 | 0.560 |
Why?
|
Central Nervous System Diseases | 1 | 2021 | 518 | 0.550 |
Why?
|
Angiogenesis Inhibitors | 7 | 2021 | 2056 | 0.540 |
Why?
|
Radiotherapy | 4 | 2019 | 1494 | 0.510 |
Why?
|
Enteric Nervous System | 2 | 2016 | 213 | 0.500 |
Why?
|
Cognition Disorders | 5 | 2019 | 3967 | 0.490 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2023 | 9373 | 0.490 |
Why?
|
Glutarates | 5 | 2021 | 243 | 0.480 |
Why?
|
Humans | 126 | 2024 | 765968 | 0.480 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2016 | 135 | 0.480 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 633 | 0.470 |
Why?
|
Protein Kinase Inhibitors | 5 | 2024 | 5696 | 0.450 |
Why?
|
Stem Cell Transplantation | 4 | 2016 | 1602 | 0.450 |
Why?
|
Regeneration | 2 | 2017 | 1517 | 0.440 |
Why?
|
Cell Transplantation | 1 | 2016 | 473 | 0.440 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2024 | 3672 | 0.430 |
Why?
|
Spinal Cord Neoplasms | 1 | 2015 | 258 | 0.410 |
Why?
|
Photons | 3 | 2024 | 572 | 0.390 |
Why?
|
Lymphoma, B-Cell | 2 | 2019 | 943 | 0.390 |
Why?
|
Muscle Weakness | 1 | 2015 | 413 | 0.380 |
Why?
|
Medulloblastoma | 1 | 2017 | 658 | 0.380 |
Why?
|
Diagnostic Imaging | 2 | 2017 | 3529 | 0.370 |
Why?
|
Back Pain | 1 | 2015 | 544 | 0.360 |
Why?
|
Neuroglia | 4 | 2015 | 964 | 0.350 |
Why?
|
Meningeal Carcinomatosis | 2 | 2021 | 65 | 0.350 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2412 | 0.340 |
Why?
|
Bone Marrow Transplantation | 1 | 2017 | 2729 | 0.330 |
Why?
|
Magnetic Resonance Imaging | 22 | 2024 | 36532 | 0.330 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2023 | 11868 | 0.310 |
Why?
|
Neural Stem Cells | 1 | 2016 | 898 | 0.300 |
Why?
|
Combined Modality Therapy | 8 | 2023 | 8529 | 0.300 |
Why?
|
Adult | 47 | 2024 | 223044 | 0.300 |
Why?
|
Cell Lineage | 4 | 2010 | 2573 | 0.300 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5753 | 0.290 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3513 | 0.290 |
Why?
|
Brain Diseases | 3 | 2018 | 1546 | 0.290 |
Why?
|
Male | 55 | 2024 | 363698 | 0.280 |
Why?
|
Lateral Ventricles | 2 | 2021 | 142 | 0.280 |
Why?
|
Drug Evaluation | 1 | 2008 | 641 | 0.280 |
Why?
|
Necrosis | 3 | 2020 | 1617 | 0.270 |
Why?
|
Lower Extremity | 1 | 2015 | 1226 | 0.270 |
Why?
|
Hydrothorax | 1 | 2006 | 20 | 0.270 |
Why?
|
Retrospective Studies | 20 | 2024 | 81514 | 0.270 |
Why?
|
Meningeal Neoplasms | 3 | 2022 | 1252 | 0.270 |
Why?
|
Middle Aged | 41 | 2024 | 223009 | 0.260 |
Why?
|
Mutation | 14 | 2024 | 30198 | 0.260 |
Why?
|
Bone Marrow | 1 | 2016 | 2921 | 0.260 |
Why?
|
Multiple Myeloma | 1 | 2023 | 5197 | 0.250 |
Why?
|
Aged | 34 | 2024 | 171117 | 0.240 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2648 | 0.240 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2005 | 8 | 0.240 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10261 | 0.240 |
Why?
|
Cell Culture Techniques | 2 | 2002 | 1652 | 0.240 |
Why?
|
Female | 52 | 2024 | 396112 | 0.230 |
Why?
|
Neurons | 6 | 2015 | 9525 | 0.230 |
Why?
|
Fatal Outcome | 2 | 2020 | 1831 | 0.220 |
Why?
|
Herpesvirus 6, Human | 1 | 2004 | 97 | 0.220 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2570 | 0.210 |
Why?
|
Radiosurgery | 3 | 2023 | 1328 | 0.210 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2005 | 564 | 0.200 |
Why?
|
Therapies, Investigational | 1 | 2023 | 110 | 0.200 |
Why?
|
B-Cell Maturation Antigen | 1 | 2023 | 148 | 0.200 |
Why?
|
Astrocytes | 3 | 2005 | 1345 | 0.200 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2021 | 640 | 0.200 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1352 | 0.190 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2023 | 276 | 0.190 |
Why?
|
DNA Modification Methylases | 2 | 2020 | 207 | 0.190 |
Why?
|
Gangliosides | 1 | 2002 | 132 | 0.190 |
Why?
|
Loss of Heterozygosity | 1 | 2024 | 663 | 0.190 |
Why?
|
Oligodendroglia | 1 | 2006 | 542 | 0.190 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1927 | 0.190 |
Why?
|
Prognosis | 14 | 2024 | 29922 | 0.190 |
Why?
|
Cell Differentiation | 6 | 2009 | 11641 | 0.180 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2120 | 0.180 |
Why?
|
DNA Repair Enzymes | 2 | 2020 | 342 | 0.180 |
Why?
|
Inositol | 1 | 2021 | 215 | 0.180 |
Why?
|
Epilepsy, Generalized | 1 | 2023 | 183 | 0.180 |
Why?
|
Maximum Tolerated Dose | 2 | 2020 | 898 | 0.170 |
Why?
|
Echo-Planar Imaging | 1 | 2024 | 648 | 0.170 |
Why?
|
Neurosurgical Procedures | 2 | 2024 | 2074 | 0.170 |
Why?
|
Quinolines | 2 | 2016 | 769 | 0.170 |
Why?
|
Meningioma | 2 | 2022 | 1221 | 0.170 |
Why?
|
Peritoneal Neoplasms | 1 | 2006 | 703 | 0.170 |
Why?
|
Disease Management | 3 | 2020 | 2535 | 0.170 |
Why?
|
Neurosciences | 1 | 2024 | 385 | 0.170 |
Why?
|
Animals | 18 | 2024 | 168764 | 0.160 |
Why?
|
Epilepsies, Partial | 1 | 2023 | 431 | 0.160 |
Why?
|
Brain Injuries | 2 | 2024 | 2060 | 0.160 |
Why?
|
Neurogenesis | 2 | 2016 | 866 | 0.160 |
Why?
|
Stuttering | 1 | 2018 | 24 | 0.160 |
Why?
|
Demyelinating Diseases | 2 | 2015 | 355 | 0.150 |
Why?
|
Protons | 1 | 2023 | 1073 | 0.150 |
Why?
|
Signal Transduction | 2 | 2012 | 23601 | 0.150 |
Why?
|
Treatment Outcome | 13 | 2024 | 65188 | 0.150 |
Why?
|
Intracranial Hemorrhages | 1 | 2003 | 814 | 0.150 |
Why?
|
Young Adult | 11 | 2024 | 59889 | 0.150 |
Why?
|
Disease Progression | 5 | 2022 | 13632 | 0.140 |
Why?
|
Pyridazines | 1 | 2019 | 200 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 654 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2003 | 786 | 0.140 |
Why?
|
Radiotherapy Dosage | 2 | 2023 | 2865 | 0.140 |
Why?
|
Head | 1 | 2023 | 925 | 0.140 |
Why?
|
Cholinesterase Inhibitors | 1 | 2019 | 241 | 0.140 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13451 | 0.140 |
Why?
|
Folic Acid | 1 | 2023 | 1338 | 0.130 |
Why?
|
Survival Rate | 7 | 2024 | 12795 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.130 |
Why?
|
Capillary Permeability | 1 | 2019 | 768 | 0.130 |
Why?
|
Neurology | 1 | 2024 | 785 | 0.130 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 318 | 0.130 |
Why?
|
Neurodegenerative Diseases | 1 | 2005 | 1087 | 0.130 |
Why?
|
Mice | 7 | 2024 | 81819 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 703 | 0.120 |
Why?
|
Pituitary Neoplasms | 1 | 2024 | 1321 | 0.120 |
Why?
|
Antineoplastic Protocols | 1 | 2015 | 47 | 0.120 |
Why?
|
Forecasting | 2 | 2019 | 2936 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12976 | 0.120 |
Why?
|
Serotonin 5-HT4 Receptor Agonists | 1 | 2015 | 11 | 0.120 |
Why?
|
Karnofsky Performance Status | 4 | 2019 | 163 | 0.120 |
Why?
|
Corpus Callosum | 2 | 2014 | 751 | 0.120 |
Why?
|
Optic Nerve Neoplasms | 1 | 2015 | 45 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2017 | 1624 | 0.120 |
Why?
|
Melanoma | 2 | 2023 | 5719 | 0.120 |
Why?
|
Methylphenidate | 1 | 2019 | 479 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1963 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 582 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 4 | 2024 | 4034 | 0.120 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2207 | 0.120 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 2014 | 42 | 0.110 |
Why?
|
Erythropoietin | 1 | 2019 | 716 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2004 | 2844 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59489 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7425 | 0.110 |
Why?
|
Promoter Regions, Genetic | 2 | 2024 | 5786 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1162 | 0.110 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 536 | 0.110 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 660 | 0.110 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39193 | 0.110 |
Why?
|
Valproic Acid | 1 | 2016 | 445 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 2796 | 0.100 |
Why?
|
Gene Rearrangement | 1 | 2017 | 1144 | 0.100 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5389 | 0.100 |
Why?
|
Cells, Cultured | 4 | 2016 | 18973 | 0.100 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14751 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 538 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3850 | 0.100 |
Why?
|
Stereotaxic Techniques | 1 | 2014 | 551 | 0.090 |
Why?
|
Child | 6 | 2023 | 80564 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1587 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5337 | 0.090 |
Why?
|
Cell Division | 3 | 2004 | 4475 | 0.090 |
Why?
|
Colitis | 2 | 2021 | 1239 | 0.090 |
Why?
|
Laser Therapy | 1 | 2018 | 1108 | 0.090 |
Why?
|
Electroencephalography | 4 | 2023 | 6273 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2002 | 3607 | 0.090 |
Why?
|
Macrophages | 2 | 2017 | 5772 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2015 | 614 | 0.090 |
Why?
|
Central Nervous System Stimulants | 1 | 2019 | 1167 | 0.090 |
Why?
|
Prospective Studies | 10 | 2024 | 54802 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1787 | 0.080 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3946 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2339 | 0.080 |
Why?
|
Nitriles | 1 | 2014 | 982 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3596 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2659 | 0.080 |
Why?
|
Aniline Compounds | 1 | 2014 | 1075 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6364 | 0.080 |
Why?
|
Genotype | 1 | 2023 | 13024 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3715 | 0.080 |
Why?
|
Genetic Variation | 1 | 2004 | 6610 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 974 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2015 | 1410 | 0.080 |
Why?
|
Indoles | 2 | 2014 | 1839 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2017 | 2423 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2226 | 0.070 |
Why?
|
Monocytes | 1 | 2017 | 2595 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2016 | 10429 | 0.070 |
Why?
|
Brain Damage, Chronic | 1 | 2009 | 265 | 0.070 |
Why?
|
Bromodeoxyuridine | 2 | 2008 | 310 | 0.070 |
Why?
|
Nausea | 2 | 2021 | 680 | 0.070 |
Why?
|
Epilepsy | 1 | 2023 | 3320 | 0.070 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1635 | 0.070 |
Why?
|
Echoencephalography | 1 | 2007 | 133 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2080 | 0.070 |
Why?
|
Disease-Free Survival | 4 | 2020 | 6832 | 0.070 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2007 | 235 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4424 | 0.070 |
Why?
|
Adolescent | 7 | 2021 | 88835 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2329 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2018 | 4850 | 0.060 |
Why?
|
Doxorubicin | 2 | 2004 | 2230 | 0.060 |
Why?
|
Cell Survival | 1 | 2016 | 5747 | 0.060 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1873 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4520 | 0.060 |
Why?
|
Mice, Inbred CBA | 1 | 2006 | 439 | 0.060 |
Why?
|
Survival Analysis | 5 | 2021 | 10070 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2410 | 0.060 |
Why?
|
Child, Preschool | 2 | 2018 | 42500 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8611 | 0.060 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2004 | 152 | 0.060 |
Why?
|
Rats | 4 | 2009 | 23707 | 0.060 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2004 | 38 | 0.060 |
Why?
|
Myelin Sheath | 1 | 2008 | 652 | 0.060 |
Why?
|
Ifosfamide | 1 | 2003 | 233 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4900 | 0.050 |
Why?
|
Germinoma | 1 | 2003 | 124 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2004 | 412 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4353 | 0.050 |
Why?
|
Fluorouracil | 1 | 2008 | 1648 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18293 | 0.050 |
Why?
|
S Phase | 1 | 2004 | 424 | 0.050 |
Why?
|
G1 Phase | 1 | 2004 | 403 | 0.050 |
Why?
|
Neurotrophin 3 | 1 | 2002 | 61 | 0.050 |
Why?
|
Sialic Acids | 1 | 2002 | 119 | 0.050 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2002 | 43 | 0.050 |
Why?
|
Oligodendroglioma | 1 | 2004 | 273 | 0.050 |
Why?
|
Carbamazepine | 1 | 2023 | 222 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2017 | 14448 | 0.050 |
Why?
|
Etoposide | 1 | 2003 | 636 | 0.050 |
Why?
|
Oxygen | 1 | 2013 | 4241 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6499 | 0.050 |
Why?
|
Brain Tissue Transplantation | 1 | 2002 | 81 | 0.050 |
Why?
|
Glutamine | 1 | 2024 | 576 | 0.050 |
Why?
|
Seizures | 2 | 2023 | 3000 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3356 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4209 | 0.050 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 919 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 153 | 0.050 |
Why?
|
Patient Advocacy | 1 | 2023 | 361 | 0.040 |
Why?
|
Glycolysis | 1 | 2024 | 838 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2024 | 2631 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22332 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2002 | 594 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2007 | 861 | 0.040 |
Why?
|
Electronics | 1 | 2021 | 314 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 24282 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 629 | 0.040 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2020 | 71 | 0.040 |
Why?
|
Anticonvulsants | 2 | 2023 | 1921 | 0.040 |
Why?
|
Procarbazine | 1 | 2019 | 172 | 0.040 |
Why?
|
Lomustine | 1 | 2019 | 60 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15842 | 0.040 |
Why?
|
Biological Products | 2 | 2019 | 942 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 227 | 0.040 |
Why?
|
Cohort Studies | 3 | 2019 | 41649 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1978 | 0.040 |
Why?
|
Tretinoin | 1 | 2002 | 524 | 0.040 |
Why?
|
Organ Size | 1 | 2024 | 2260 | 0.040 |
Why?
|
Telomerase | 1 | 2024 | 749 | 0.040 |
Why?
|
Mood Disorders | 1 | 2006 | 1128 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1742 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.040 |
Why?
|
Receptor, TIE-2 | 1 | 2019 | 183 | 0.040 |
Why?
|
Cell Death | 1 | 2004 | 1679 | 0.040 |
Why?
|
Fetus | 2 | 2004 | 1870 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 350 | 0.040 |
Why?
|
Survivors | 1 | 2009 | 2372 | 0.040 |
Why?
|
Biological Evolution | 1 | 2004 | 1072 | 0.040 |
Why?
|
Glutamic Acid | 1 | 2004 | 1180 | 0.040 |
Why?
|
Dura Mater | 1 | 2020 | 296 | 0.040 |
Why?
|
Tumor Burden | 1 | 2023 | 1885 | 0.040 |
Why?
|
Synaptic Transmission | 1 | 2004 | 1175 | 0.040 |
Why?
|
Cisplatin | 1 | 2003 | 1658 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2006 | 8102 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2023 | 978 | 0.040 |
Why?
|
Vincristine | 1 | 2019 | 1039 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2003 | 1272 | 0.030 |
Why?
|
Ischemia | 1 | 2006 | 1909 | 0.030 |
Why?
|
Lactams | 1 | 2017 | 159 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10729 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 647 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 502 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 548 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 561 | 0.030 |
Why?
|
Hippocampus | 1 | 2008 | 3775 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15747 | 0.030 |
Why?
|
Deoxyuridine | 1 | 2015 | 34 | 0.030 |
Why?
|
Water | 1 | 2021 | 1417 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1328 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2652 | 0.030 |
Why?
|
Integrin alpha2 | 1 | 2015 | 38 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2004 | 11022 | 0.030 |
Why?
|
Ablation Techniques | 1 | 2018 | 254 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40065 | 0.030 |
Why?
|
Point Mutation | 1 | 2000 | 1590 | 0.030 |
Why?
|
Thiotepa | 1 | 2014 | 66 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2023 | 12509 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1385 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1216 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1549 | 0.030 |
Why?
|
Up-Regulation | 2 | 2019 | 4137 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2015 | 255 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1603 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2015 | 186 | 0.030 |
Why?
|
Base Sequence | 1 | 2005 | 12403 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 576 | 0.030 |
Why?
|
Busulfan | 1 | 2014 | 264 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2024 | 2892 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2023 | 8923 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 282 | 0.030 |
Why?
|
Chick Embryo | 1 | 2015 | 964 | 0.030 |
Why?
|
Quality of Life | 4 | 2023 | 13462 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2900 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17533 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4335 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2008 | 17075 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21056 | 0.030 |
Why?
|
Cytarabine | 1 | 2014 | 698 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17594 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1007 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2018 | 962 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1393 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7123 | 0.020 |
Why?
|
Health Policy | 1 | 2024 | 2698 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 691 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2020 | 2475 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1899 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3584 | 0.020 |
Why?
|
NF-kappa B | 1 | 2019 | 2485 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1701 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14652 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2517 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2229 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2307 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4893 | 0.020 |
Why?
|
Autopsy | 1 | 2013 | 1011 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3458 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2228 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4015 | 0.020 |
Why?
|
Models, Statistical | 1 | 2023 | 5089 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2008 | 92 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2844 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13266 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1364 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 2033 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2008 | 610 | 0.020 |
Why?
|
Colon | 1 | 2015 | 1795 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4671 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4533 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3807 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 684 | 0.020 |
Why?
|
Auditory Pathways | 1 | 2008 | 241 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11206 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4255 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7584 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9249 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1984 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15398 | 0.020 |
Why?
|
Phenotype | 1 | 2002 | 16721 | 0.010 |
Why?
|
Excitatory Amino Acid Transporter 4 | 1 | 2004 | 4 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7421 | 0.010 |
Why?
|
Glutamate Plasma Membrane Transport Proteins | 1 | 2004 | 10 | 0.010 |
Why?
|
Excitatory Amino Acid Transporter 1 | 1 | 2004 | 18 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6069 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2000 | 5767 | 0.010 |
Why?
|
Excitatory Amino Acid Transporter 3 | 1 | 2004 | 32 | 0.010 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2004 | 163 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6547 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 14071 | 0.010 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2004 | 89 | 0.010 |
Why?
|
Infant | 1 | 2005 | 36386 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5881 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4025 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10383 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9550 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8237 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8875 | 0.010 |
Why?
|
Symporters | 1 | 2004 | 362 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2627 | 0.010 |
Why?
|
DNA, Antisense | 1 | 2000 | 44 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1529 | 0.010 |
Why?
|
Action Potentials | 1 | 2008 | 1838 | 0.010 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2000 | 54 | 0.010 |
Why?
|
Drug Carriers | 1 | 2004 | 700 | 0.010 |
Why?
|
Tamoxifen | 1 | 2004 | 963 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1718 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 1145 | 0.010 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2004 | 844 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2004 | 1188 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2004 | 2669 | 0.010 |
Why?
|
Germany | 1 | 2000 | 882 | 0.010 |
Why?
|
Liposomes | 1 | 2001 | 788 | 0.010 |
Why?
|
X Chromosome | 1 | 2000 | 819 | 0.010 |
Why?
|
DNA Primers | 1 | 2000 | 2825 | 0.010 |
Why?
|
Remission Induction | 1 | 2001 | 2411 | 0.010 |
Why?
|
Syndrome | 1 | 2000 | 3271 | 0.010 |
Why?
|
Reoperation | 1 | 2003 | 4294 | 0.010 |
Why?
|
Pedigree | 1 | 2000 | 4526 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4331 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15543 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20124 | 0.010 |
Why?
|
Models, Biological | 1 | 2004 | 9443 | 0.000 |
Why?
|